Ascendis Pharma A (ASND) Debt Ratio (2021 - 2026)
Ascendis Pharma A (ASND) posted Debt Ratio of 0.37 for Q1 2026, down 55.15% sequentially from 0.82 in Q4 2025, and down 60.12% YoY from 0.92 in Q1 2025.
Ascendis Pharma A (ASND) Debt Ratio (2021 - 2026) Analysis & Trends
Ascendis Pharma A has reported Debt Ratio for 6 years, with the latest figure at 0.37 in Q1 2026.
- Quarterly Debt Ratio fell 60.12% year-over-year to 0.37 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.37 (down 60.12% YoY) and the FY2025 annual result came in at 0.82, up 214.07% from the prior year.
- Debt Ratio eased to 0.37 in Q1 2026 per ASND's latest filing, from 0.82 in the prior quarter.
- Over five years, Debt Ratio peaked at 1.07 in Q2 2024 and troughed at 0.26 in Q4 2024.
- A 5-year average of 0.66 and a median of 0.64 in 2023 frame the typical range for Debt Ratio.
- The sharpest annual moves came in 2022 and 2024: Debt Ratio jumped 597.33% in 2022, then sank 65.7% in 2024.
- Over 5 years, Debt Ratio stood at 0.37 in 2022, then soared by 108.35% to 0.76 in 2023, then tumbled by 65.7% to 0.26 in 2024, then soared by 214.07% to 0.82 in 2025, then plunged by 55.15% to 0.37 in 2026.
- According to Business Quant data, Debt Ratio over the past three periods registered 0.37, 0.82, and 0.86 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.05 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.12 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.47 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.26 |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.37 |
| Dec 31, 2025 | 0.82 |
| Sep 30, 2025 | 0.86 |
| Jun 30, 2025 | 0.86 |
| Mar 31, 2025 | 0.92 |
| Dec 31, 2024 | 0.26 |
| Sep 30, 2024 | 0.85 |
| Jun 30, 2024 | 1.07 |
| Mar 31, 2024 | 1.06 |
| Dec 31, 2023 | 0.76 |
| Sep 30, 2023 | 0.64 |
| Jun 30, 2023 | 0.61 |
| Mar 31, 2023 | 0.52 |
| Dec 31, 2022 | 0.37 |
| Sep 30, 2022 | 0.43 |
| Jun 30, 2022 | 0.39 |
| Mar 31, 2022 | 0.34 |
| Dec 31, 2021 | 0.05 |